ExSight Ventures is an early-stage ophthalmic investor that specializes in investing in innovative ophthalmic diagnostic and treatment solutions. They address the lack of early-stage funding available to life science companies.

ExSight Ventures

Pound Sterling

Squarespace Hosted

Business Management

Alan M. Spiro, Jd, Phd

Partner

James Murray

Maneesha Ghiya

Randolph Cohen

Adam Benowitz

Partner & Co-Founder

Firas Rahhal

Alan Spiro

Advisor

Michael Nissen

DTx Pharma is a biotechnology company creating novel RNA-based therapeutics to treat the genetic drivers of disease.

RetroSense Therapeutics is a biotechnology company developing gene therapy for vision restoration.

Investors Active in Greater Los Angeles Area

Early Stage Venture Investors with Investments in Greater Los Angeles Area

United States Venture Capital Investors (Top 10K)

Early Stage Venture Investors with Investments in Michigan

ExSight Ventures is a venture capital firm specializing in early-stage impact investments in innovative ophthalmic diagnostic and treatment solutions.  The firm consists of 2 accomplished retinal surgeons and a team of investment professionals that have partnered to address the need for funding early-stage ophthalmic-focused companies.  The firm seeks investments in biotechnology, medical devices, pharmaceuticals and software solutions in ophthalmology.

New York

United States

North America

Re-Vana Therapeutics Raises $3.25 Million in Pre-Series A Financing

Nigeria

Africa

Israel

Asia

India

ExSight Ventures is a life sciences venture capital firm specializing in early-stage investments in innovative ophthalmic diagnostic and treatment solutions.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Oct 25, 2024 5:37 AM	3d9aa262
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Oct 25, 2024 5:37 AM	e68e5822
crunchbase trigger	general	Nov 25, 2024 9:09 AM	78ec57d9
crunchbase profile	general	Nov 25, 2024 12:18 PM	f99324cd
li profile	general
translate crunchbase fundingrounds	general	Nov 25, 2024 2:18 PM	5735fda5
peers	general	Oct 25, 2024 5:37 AM	6379ea16
news basic	general	Oct 25, 2024 5:37 AM	fdbca636
bundesanzeiger	filings
financials download nd	financials
private financials	financials

EXSI

COM:EXSIGHTVENTURES

ExSight Ventures